Kyverna Therapeutics: "Strong Buy" Rating As Positive SPS Data Leads To 1st Half 2026 BLA Filing

Kyverna Therapeutics: "Strong Buy" Rating As Positive SPS Data Leads To 1st Half 2026 BLA Filing#Kyverna #Therapeutics #quotStrong #Buyquot #Rating #Positive #SPS #Data #Leads #1st #BLA #Filing